Approving a Process, Not a Pill
8:42–9:14 · 32s
Moderna’s CEO explains the regulatory paradigm shift: the FDA will certify their manufacturing process rather than a single drug because every patient’s medicine is chemically unique.
8:42–9:14 · 32s
Moderna’s CEO explains the regulatory paradigm shift: the FDA will certify their manufacturing process rather than a single drug because every patient’s medicine is chemically unique.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.